Pulse Biosciences(PLSE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PLSE Pulse Biosciences

Not Yet Opened 06-03 16:00:00 EDT

24.99

+0.71

+2.92%

盘后24.99

+0.000.00%

18:04 EDT

High25.24	Low23.67	Vol261.52K
Open24.27	D1 Closing24.28	Amplitude6.47%
Mkt Cap1.73B	Tradable Cap476.21M	Total Shares69.21M
T/O6.48M	T/O Rate1.37%	Tradable Shares19.06M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PLSE","market":"US","secType":"STK","nameCN":"Pulse Biosciences","latestPrice":24.99,"timestamp":1780516800000,"preClose":24.28,"halted":0,"volume":261521,"hourTrading":{"tag":"盘后","latestPrice":24.99,"preClose":24.99,"latestTime":"18:04 EDT","volume":2787,"amount":69641.83,"timestamp":1780524241129,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.029242174629324436,"floatShares":19056000,"shares":69209700,"eps":-1.102858,"marketStatus":"Not Yet Opened","change":0.71,"latestTime":"06-03 16:00:00 EDT","open":24.27,"high":25.24,"low":23.67,"amount":6484940.944378001,"amplitude":0.064662,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.102858,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780560000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1463544000000,"exchange":"NASDAQ","adjPreClose":24.28,"postHourTrading":{"tag":"盘后","latestPrice":24.99,"preClose":24.99,"latestTime":"18:04 EDT","volume":2787,"amount":69641.83,"timestamp":1780524241129,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.047382,"impliedVol":0.5826,"impliedVolPercentile":0.5817},"requestUrl":"/m/hq/s/PLSE/tweets","defaultTab":"tweets","newsList":[{"id":"2639603100","title":"Pulse Biosciences (PLSE) Valuation Check After Strong Recent Share Price Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2639603100","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639603100?lang=en_us&edition=fundamental","pubTime":"2026-05-30 08:15","pubTimestamp":1780100110,"startTime":"0","endTime":"0","summary":"What recent performance tells you about Pulse Biosciences stock\nPulse Biosciences (PLSE) has drawn attention after a period of strong share price moves, with the stock up about 24% over the past month and about 34% over the past 3 months.\nFor context, the Miami based bioelectric medicine company has a market value of about US$1.71b and focuses on its nPulse system platform across dermatology and cardiac applications, an area many investors track closely in the healthcare segment.\nSee our...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/pulse-biosciences-plse-valuation-check-after-strong-recent-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-plse/pulse-biosciences/news/pulse-biosciences-plse-valuation-check-after-strong-recent-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638635167","title":"Pulse Biosciences to present at Goldman Sachs Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2638635167","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638635167?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:07","pubTimestamp":1779912476,"startTime":"0","endTime":"0","summary":"Pulse Biosciences will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026, at 10:00 a.m. ET.The event is scheduled to take place in Miami Beach, Florida.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL5BghNT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2750360997.AUD","IE0004091025.USD","LU0251142724.SGD","LU2237443978.SGD","LU0345770308.USD","LU0048573561.USD","BK4585","IE0004086264.USD","IE00BSNM7G36.USD","LU2237443622.USD","LU0868494617.USD","BK4082","LU2750360641.GBP","BK4552","BK4550","BK4127","BK4588","IE0002270589.USD","LU2471134796.USD","LU0345770993.USD","LU0061475181.USD","IE00BFXG1179.USD","LU2237443549.SGD","LU1868837136.USD","LU2471134523.USD","LU1804176565.USD","BK4516","LU0251131958.USD","LU2237438978.USD","LU2265009873.SGD","IE0034235188.USD","LU1791807156.HKD","LU1894683264.USD","LU1868836914.USD","LU0106831901.USD","BK4533","LU0742534661.SGD","LU1894683348.USD","LU0942090050.USD","LU1668664300.SGD","PLSE","IE00B19Z3B42.SGD","LU0096364046.USD","LU0868494708.USD","GSX","LU2237443895.HKD","LU1868836591.USD","LU2237443465.HKD","BK4504","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636181968","title":"Pulse Biosciences Earnings Call Highlights Clinical Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2636181968","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636181968?lang=en_us&edition=fundamental","pubTime":"2026-05-20 13:37","pubTimestamp":1779255450,"startTime":"0","endTime":"0","summary":"Pulse Biosciences Inc (($PLSE)) has held its Q1 earnings call. Read on for the main highlights of the call. Pulse Biosciences’ latest earnings call...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-earnings-call-highlights-clinical-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-earnings-call-highlights-clinical-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635102217","title":"Pulse Biosciences Q1 FY26 net loss widens to $18.58 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635102217","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635102217?lang=en_us&edition=fundamental","pubTime":"2026-05-14 21:03","pubTimestamp":1778763829,"startTime":"0","endTime":"0","summary":"Pulse Biosciences posted a wider net loss of USD 18.58 million for the quarter ended March 31, 2026, compared with USD 16.8 million a year earlier.Revenue turned positive to USD 401,000, driven by limited market release commercial sales of the Vybrance Percutaneous Electrode System.Operating loss widened to USD 19.15 million as research and development expense rose to USD 12.59 million.Cash and cash equivalents totaled USD 68.3 million at March 31, 2026; Pulse expects existing resources plus net proceeds from a May 2026 at-the-market sale of USD 12.9 million to fund operations for at least 12 months from the filing date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulse Biosciences Inc. published the original content used to generat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL43GmJ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634765218","title":"BRIEF-ATM Equity Purchases By Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634765218","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634765218?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:04","pubTimestamp":1778583848,"startTime":"0","endTime":"0","summary":"BRIEF-ATM Equity Purchases By Pulse Biosciences' Co-Chairmen Total Approximately $13.3 MillionMay 12 (Reuters) - Pulse Biosciences Inc PLSE.O:ATM EQUITY PURCHASES BY PULSE BIOSCIENCES’ CO-CHAIRMEN TOT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P0T2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634218171","title":"Atm Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634218171","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634218171?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:01","pubTimestamp":1778583676,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P0T2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139131653","title":"Stock Track | Pulse Biosciences Soars 5.40% in Night Session on Insider Buying by CEO and Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1139131653","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139131653?lang=en_us&edition=fundamental","pubTime":"2026-05-12 09:02","pubTimestamp":1778547771,"startTime":"0","endTime":"0","summary":"Pulse Biosciences (PLSE) stock surged 5.40% during the night session on Monday, marking a significant 24-hour gain for the medical technology company.The sharp rise appears to be driven by positive...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634256353","title":"Pulse Biosciences director Robert W. Duggan acquires 660,233 shares for $13 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634256353","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634256353?lang=en_us&edition=fundamental","pubTime":"2026-05-12 06:52","pubTimestamp":1778539965,"startTime":"0","endTime":"0","summary":"Pulse Biosciences director Robert W. Duggan, 10% owner, bought 660,233 common shares at $19.69.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulse Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLbSnMh7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Pulse Biosciences director Robert W. Duggan acquires 660,233 shares for $13 million","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634495486","title":"Pulse Biosciences Races Ahead on AF Trial Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2634495486","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634495486?lang=en_us&edition=fundamental","pubTime":"2026-05-09 08:56","pubTimestamp":1778288207,"startTime":"0","endTime":"0","summary":"Pulse Biosciences Inc (($PLSE)) has held its Q1 earnings call. Read on for the main highlights of the call. Pulse Biosciences’ latest earnings call...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-races-ahead-on-af-trial-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-races-ahead-on-af-trial-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633430996","title":"Pulse Biosciences to present at BofA Securities 2026 Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2633430996","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633430996?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:00","pubTimestamp":1778238022,"startTime":"0","endTime":"0","summary":"Pulse Biosciences scheduled to present at BofA Securities 2026 Healthcare Conference in Las Vegas on May 13 at 4:35 p.m. PT.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL5YxLHP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1035773651.USD","LU0321505439.SGD","IE0002270589.USD","BK4581","LU1894683264.USD","LU0868494617.USD","LU0980610538.SGD","LU2129689431.USD","LU1366192091.USD","IE00BLSP4452.SGD","PLSE","LU2133065610.SGD","LU0648001328.SGD","LU1496350171.SGD","LU0234570918.USD","IE00B19Z3B42.SGD","LU0203347892.USD","LU2265009873.SGD","BAC","LU1668664300.SGD","IE00BLSP4239.USD","LU0170899867.USD","LU1894683348.USD","LU0477156797.USD","IE0001KFT4U8.USD","LU0130518102.USD","BK4553","LU0306806265.USD","LU0321505868.SGD","LU0640476718.USD","BK4585","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0310800965.SGD","LU0053666078.USD","LU0234572021.USD","IE00B7SZLL34.SGD","LU0203345920.USD","LU0314106906.USD","LU0320765489.SGD","LU0098860793.USD","IE00B19Z3581.USD","LU0130517989.USD","LU0128525689.USD","LU1069347547.HKD","LU1880398554.USD","LU0106831901.USD","LU1804176565.USD","LU0971096721.USD","LU1880398471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633666139","title":"Pulse Biosciences Authorizes Insider Purchases Under Equity Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2633666139","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633666139?lang=en_us&edition=fundamental","pubTime":"2026-05-06 21:36","pubTimestamp":1778074612,"startTime":"0","endTime":"0","summary":"Pulse Biosciences ( ($PLSE) ) has shared an update. On May 5, 2026, Pulse Biosciences’ board authorized TD Securities (USA) LLC, acting as sales ag...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-authorizes-insider-purchases-under-equity-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-authorizes-insider-purchases-under-equity-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","PLSE","USA","BK4585","BK4215","BK4588","EQR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633138333","title":"Pulse Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633138333","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633138333?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:00","pubTimestamp":1778068834,"startTime":"0","endTime":"0","summary":"Pulse Biosciences Inc reports results for the quarter ended March 31 - Earnings SummaryPulse Biosciences Inc PLSE.OQ reported a quarterly adjusted loss of 24 cents per share for the quarter ended Marc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL8N41J1SX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632895930","title":"Pulse Biosciences Highlights Q1 Results, Electrophysiology Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2632895930","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632895930?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:50","pubTimestamp":1777902617,"startTime":"0","endTime":"0","summary":"Pulse Biosciences ( ($PLSE) ) has issued an update. On May 4, 2026, Pulse Biosciences reported first-quarter 2026 results and a sharpened strategic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-highlights-q1-results-electrophysiology-focus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-highlights-q1-results-electrophysiology-focus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632937975","title":"Earnings Flash (PLSE) Pulse Biosciences Posts Q1 Loss $0.27 a Share, vs. FactSet Est of $0.32 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2632937975","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632937975?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:04","pubTimestamp":1777892687,"startTime":"0","endTime":"0","summary":"Earnings Flash (PLSE) Pulse Biosciences Posts Q1 Loss $0.27 a Share, vs. FactSet Est of $0.32 Loss","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632635937","title":"Pulse Biosciences Q1 FY26 net loss widens to $18.6 million; revenue rises to $401,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2632635937","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632635937?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:01","pubTimestamp":1777892504,"startTime":"0","endTime":"0","summary":"Pulse Biosciences posted Q1 GAAP net loss of USD 18.6 million, widening from USD 16.8 million a year earlier; net loss per share widened to USD 0.27 from USD 0.25.Revenue rose to USD 401,000 from no revenue a year earlier.Total GAAP costs and expenses increased to USD 19.6 million from USD 18.0 million, due to increased investment in clinical programs, partially offset by lower stock-based compensation expense.Cash and cash equivalents fell to USD 68.3 million as of March 31, 2026 from USD 80.7 million at Dec. 31, 2025; cash used in operating activities totaled USD 14.6 million.Started enrollment in NANOPULSE-AF, a U.S. IDE pivotal trial for endocardial catheter AF ablation, with enrollment now expected to complete in early Q4 2026; continued progress on NANOCLAMP-AF with enrollment expected to complete by end of first half of 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDLcbpkM4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632937517","title":"BRIEF-Pulse Biosciences Q1 Net Income USD -18.581 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2632937517","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632937517?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:00","pubTimestamp":1777892446,"startTime":"0","endTime":"0","summary":"BRIEF-Pulse Biosciences Q1 Net Income USD -18.581 Million\n\n\nMay 04 (Reuters) - Pulse Biosciences Q1 income from operations USD -19.15 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nPLX9973EF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632937584","title":"Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2632937584","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632937584?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:00","pubTimestamp":1777892402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUA4T6FQZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632958863","title":"Pulse Biosciences Q1 EPS USD -0.27","url":"https://stock-news.laohu8.com/highlight/detail?id=2632958863","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632958863?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:00","pubTimestamp":1777892401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nPLX9973EF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630971053","title":"Pulse Biosciences Reports Strong nPulse Atrial Fibrillation Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2630971053","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630971053?lang=en_us&edition=fundamental","pubTime":"2026-04-27 21:46","pubTimestamp":1777297572,"startTime":"0","endTime":"0","summary":"Pulse Biosciences ( ($PLSE) ) just unveiled an update. On April 25, 2026, Pulse Biosciences reported updated late‑breaking data from its first‑in‑h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-reports-strong-npulse-atrial-fibrillation-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pulse-biosciences-reports-strong-npulse-atrial-fibrillation-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630928393","title":"Pulse Biosciences reports 96% one-year success in nPulse AF catheter study","url":"https://stock-news.laohu8.com/highlight/detail?id=2630928393","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630928393?lang=en_us&edition=fundamental","pubTime":"2026-04-27 21:19","pubTimestamp":1777295960,"startTime":"0","endTime":"0","summary":"Pulse Biosciences presented updated late-breaking clinical data on April 25, 2026 at Heart Rhythm 2026 from its first-in-human feasibility study of nPulse cardiac catheter system for atrial fibrillation.Follow-up expanded to 95 patients at 6 months, 53 patients at 12 months, with results showing sustained effectiveness over time.Data indicated durable rhythm control outcomes at one year, supporting potential for a competitive long-term performance profile.Procedures remained efficient across sites, reinforcing a workflow that could support broader adoption if confirmed in later-stage studies.Safety profile remained favorable across 177 treated patients, with a low rate of serious adverse events tied to primary safety endpoint.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL29FWBY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pulsebiosciences.com","stockEarnings":[{"period":"1week","weight":0.0109},{"period":"1month","weight":0.2476},{"period":"3month","weight":0.345},{"period":"6month","weight":0.8832},{"period":"1year","weight":0.4175},{"period":"ytd","weight":0.8201}],"compareEarnings":[{"period":"1week","weight":0.005},{"period":"1month","weight":0.0505},{"period":"3month","weight":0.107},{"period":"6month","weight":0.1},{"period":"1year","weight":0.2653},{"period":"ytd","weight":0.1061}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.039406},{"month":2,"riseRate":0.4,"avgChangeRate":0.027622},{"month":3,"riseRate":0.4,"avgChangeRate":0.019181},{"month":4,"riseRate":0.5,"avgChangeRate":0.108995},{"month":5,"riseRate":0.4,"avgChangeRate":0.019334},{"month":6,"riseRate":0.454545,"avgChangeRate":0.005972},{"month":7,"riseRate":0.5,"avgChangeRate":0.013289},{"month":8,"riseRate":0.6,"avgChangeRate":0.001957},{"month":9,"riseRate":0.5,"avgChangeRate":0.125621},{"month":10,"riseRate":0.3,"avgChangeRate":0.008129},{"month":11,"riseRate":0.5,"avgChangeRate":0.107856},{"month":12,"riseRate":0.6,"avgChangeRate":0.087874}],"exchange":"NASDAQ","name":"Pulse Biosciences","nameEN":"Pulse Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pulse Biosciences(PLSE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pulse Biosciences(PLSE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pulse Biosciences,PLSE,Pulse Biosciences股票,Pulse Biosciences股票老虎,Pulse Biosciences股票老虎国际,Pulse Biosciences行情,Pulse Biosciences股票行情,Pulse Biosciences股价,Pulse Biosciences股市,Pulse Biosciences股票价格,Pulse Biosciences股票交易,Pulse Biosciences股票购买,Pulse Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pulse Biosciences(PLSE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pulse Biosciences(PLSE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction